Capital Analysts LLC Portfolio holdings
Capital Analysts is a Lincoln Investment company that provides a ready-made wealth management platform to independent financial professionals who serve affluent clients. Capital Analysts dates from 2012 and belongs to Lincoln Investment Capital Holdings; Lincoln Investment Planning, a brokerage and advisory firm under the same ownership, handles brokerage services for it and its advisors. Those advisors work across the United States as independent contractors, not employees. Their clients include individuals, high net worth individuals, trusts, foundations, businesses and charities, and Capital Analysts also offers its institutional advisory services to other advisers and trust companies. The portfolios it builds aim to be diversified and rest on asset allocation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$24.6M |
| 2 |
Goldman Sachs ETF Trust Goldman Sachs S&P 500 Premium Income ETF
GPIX
|
+$16.4M |
| 3 |
Fidelity Total Bond ETF
FBND
|
+$16.1M |
| 4 |
iShares Systematic Alternatives Active ETF
IALT
|
+$16M |
| 5 |
iShares Core Universal USD Bond ETF
IUSB
|
+$11.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoetis
ZTS
|
+$7.72M |
| 2 |
Citigroup
C
|
+$7.28M |
| 3 |
iShares Gold Trust
IAU
|
+$6.25M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$6.23M |
| 5 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$6.21M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 76.75% |
| 2 | Technology | 5.6% |
| 3 | Financials | 4.52% |
| 4 | Industrials | 2.67% |
| 5 | Healthcare | 2.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
601
First Trust Small Cap Growth AlphaDEX Fund
FYC
$1.36B
| $309K | 0.01% |
2,425
| – | – |
2025 Q1
5 quarters
|
|
602
Arista Networks
ANET
$235B
| $308K | 0.01% |
1,810
-463
| -20% | -$72.7K |
2025 Q2
4 quarters
|
|
603
Innovator Emerging Markets 10 Buffer ETF - Quarterly
EBUF
$46M
| $307K | 0.01% |
9,628
+4,017
| +72% | +$125K |
2026 Q1
1 quarter
|
|
604
Pultegroup
PHM
$25.9B
| $306K | 0.01% |
2,232
-58
| -3% | -$7.04K |
2017 Q1
37 quarters
|
|
605
AllianzIM Buffer15 Uncapped Allocation ETF
SPBU
$191M
| $306K | 0.01% |
10,130
+5,345
| +112% | +$158K |
2026 Q1
1 quarter
|
|
606
Cintas
CTAS
$88.6B
| $304K | 0.01% |
1,790
+1,245
| +228% | +$215K |
2024 Q2
8 quarters
|
|
607
FT Vest U.S. Equity Equal Weight Buffer ETF - June
RSJN
$86.7M
| $300K | 0.01% |
8,057
+3,882
| +93% | +$140K |
2024 Q2
8 quarters
|
|
608
Calamos Nasdaq-100 Structured Alt Protection ETF - September
CPNS
$28.3M
| $300K | 0.01% |
10,688
| – | – |
2024 Q3
7 quarters
|
|
609
Invesco BulletShares 2028 High Yield Corporate Bond ETF
BSJS
$786M
| $298K | 0.01% |
13,698
+23
| +0.2% | +$502 |
2023 Q1
13 quarters
|
|
610
Vanguard Short-Term Treasury ETF
VGSH
$36.7B
| $295K | 0.01% |
5,078
+215
| +4% | +$12.5K |
2023 Q2
12 quarters
|
|
611
Vanguard Morningstar Small-Cap Growth ETF
VBK
$22.6B
| $294K | 0.01% |
801
+44
| +6% | +$15K |
2021 Q2
20 quarters
|
|
612
Franklin Dynamic Municipal Bond ETF
FLMI
$2.43B
| $290K | 0.01% |
11,529
+155
| +1% | +$3.87K |
2023 Q3
11 quarters
|
|
613
Elevance Health
ELV
$90.4B
| $287K | 0.01% |
743
| – | – |
2017 Q2
36 quarters
|
|
614
General American Investors Company
GAM
$1.56B
| $286K | 0.01% |
4,483
-619
| -12% | -$39.2K |
2025 Q3
3 quarters
|
|
615
Vanguard US Momentum Factor ETF
VFMO
$1.82B
| $283K | 0.01% |
1,137
+216
| +23% | +$49.1K |
2024 Q2
8 quarters
|
|
616
FT Vest U.S. Equity Max Buffer ETF - June
JUNM
$66.5M
| $281K | 0.01% |
7,995
| – | – |
2024 Q2
8 quarters
|
|
617
Cigna
CI
$78.1B
| $280K | 0.01% |
1,014
+218
| +27% | +$61.6K |
2018 Q4
30 quarters
|
|
618
United States Lime & Minerals
USLM
$3.45B
| $280K | 0.01% |
2,675
-251
| -9% | -$29.1K |
2025 Q1
5 quarters
|
|
619
Enbridge
ENB
$106B
| $276K | 0.01% |
5,102
-410
| -7% | -$22.5K |
2019 Q1
29 quarters
|
|
620
iShares Russell Mid-Cap Growth ETF
IWP
$18.1B
| $276K | 0.01% |
1,881
-1,076
| -36% | -$148K |
2013 Q4
50 quarters
|
|
621
Capital Group Ultra Short Income ETF
CGUI
$389M
| $276K | 0.01% |
10,914
+9,120
| +508% | +$231K |
2026 Q1
1 quarter
|
|
622
Alcon
ALC
$36.3B
| $275K | 0.01% |
4,100
| – | – |
2021 Q1
21 quarters
|
|
623
Pacer US Small Cap Cash Cows Growth Leaders ETF
CAFG
$45M
| $275K | 0.01% |
8,069
-580
| -7% | -$17.9K |
2025 Q1
5 quarters
|
|
624
Invesco Aerospace & Defense ETF
PPA
$7.54B
| $275K | 0.01% |
1,559
+62
| +4% | +$10.6K |
2024 Q2
8 quarters
|
|
625
Invesco FTSE RAFI US 1000 ETF
PRF
$10.1B
| $275K | 0.01% |
5,082
+11
| +0.2% | +$573 |
2022 Q3
15 quarters
|
|
Similar funds
Capital Analysts LLC's Q2 2026 Portfolio in Review
As of Q2 2026, Capital Analysts LLC held 1,612 positions worth $4.34B, up 14% from $3.81B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Capital Analysts LLC deployed $223M of net new capital in Q2 2026, opening 75 new positions and adding to 544 existing holdings. Its largest new stake was iShares Systematic Alternatives Active ETF: 571,327 shares worth $16M.
By sector, the portfolio is most concentrated in Miscellaneous at 77% of assets, up from 75% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Zoetis, an estimated $7.72M trimmed.
- Capital Analysts LLC's largest Q2 2026 buy was iShares Systematic Alternatives Active ETF: 571,327 shares worth $16M.
- Capital Analysts LLC added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $24.6M increase.
- Capital Analysts LLC's biggest Q2 2026 reduction was Zoetis, cutting an estimated $7.72M.
- Capital Analysts LLC fully exited Hershey in Q2 2026, selling an estimated $113K.
- Capital Analysts LLC's ten largest holdings make up 30% of its $4.34B portfolio in Q2 2026.
- Capital Analysts LLC opened 75 new positions and closed 76 in Q2 2026.
- Capital Analysts LLC's portfolio value rose 14% quarter-over-quarter to $4.34B.
Based on Capital Analysts LLC's 13F filing for Q2 2026, filed 5 Aug 2026.